AI Verdict
LLY has stronger fundamentals based on our AI analysis.
ABBV vs LLY Fundamental Comparison
| Metric | ABBV | LLY |
|---|---|---|
| Revenue | $15.0B | $19.8B |
| Net Income | $695.0M | $7.4B |
| Net Margin | 4.6% | 37.4% |
| ROE | N/A | 23.7% |
| ROA | 0.5% | 6.3% |
| Current Ratio | 0.80x | 1.50x |
| Debt/Equity | N/A | 1.26x |
| EPS | $0.39 | $8.26 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
ABBV vs LLY: Frequently Asked Questions
Is ABBV or LLY a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), LLY has stronger fundamentals. ABBV is rated SELL (78% confidence) while LLY is rated BUY (86% confidence). This is not investment advice.
How does ABBV compare to LLY fundamentally?
AbbVie Inc. has ROE of N/A vs ELI LILLY & Co's 23.7%. Net margins are 4.6% vs 37.4% respectively.
Which stock pays higher dividends, ABBV or LLY?
ABBV has a dividend yield of N/A or no dividend while LLY has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in ABBV or LLY for long term?
For long-term investing, consider that ABBV has SELL rating with 78% confidence, while LLY has BUY rating with 86% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about ABBV vs LLY?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For ABBV vs LLY, the AI consensus favors LLY based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.